Effect of selected anti-cataract agents on opacification in the selenite cataract model

被引:47
作者
Hiraoka, T
Clark, JI
Li, XY
Thurston, GM
机构
[1] UNIV WASHINGTON, DEPT BIOL STRUCT 357420, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON, DEPT OPHTHALMOL, SEATTLE, WA 98195 USA
[3] OCULON CORP, CAMBRIDGE, MA 02139 USA
关键词
lens; cataract; phase separation; anti-cataract agents; selenite model; PHASE-SEPARATION INHIBITORS; LENS EPITHELIAL-CELLS; GAMMA-IV-CRYSTALLIN; CALF LENS; RAT LENS; IRRADIATED RATS; ASCORBIC-ACID; RABBIT; DEFEROXAMINE; SUPPRESSION;
D O I
10.1006/exer.1996.0002
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
A systematic study of the anti-cataract activity of 14 reagents was conducted using the selenite model. The reagents or their derivatives were identified from literature reports of their potential effectiveness against cataract formation, The effects of each reagent were measured on the phase separation temperature, T-e, of lens homogenate in vitro, T-e is a direct measure of molecular interactions leading to protein aggregation. The protective effect of a single subcutaneous injection of each reagent [at a dose of 1.5 mmol (kg body weight)(-1)] on lens opacification was evaluated in vivo using rats administered selenite [at a dose of 19 mu mol (kg body weight)(-1)] to initiate cataract formation. The strongest effects on lens opacification in vivo were observed with reagents having the strongest effect on T,, in vitro. The weakest effects in vivo were observed with the reagents having the weakest effect on T,, in vitro. The results were suggestive of a relationship between the effect of a reagent on T, and protection against cataract formation in vivo. (C) 1996 Academic Press Limited
引用
收藏
页码:11 / 19
页数:9
相关论文
共 69 条
[41]   THE ROLE OF PROTEIN-THIOL MIXED DISULFIDES IN CATARACTOGENESIS [J].
LOU, MF ;
DICKERSON, JE ;
GARADI, R .
EXPERIMENTAL EYE RESEARCH, 1990, 50 (06) :819-826
[42]   RADIOPROTECTION AGAINST CATARACT FORMATION BY WR-77913 IN GAMMA-IRRADIATED RATS [J].
MENARD, TW ;
OSGOOD, TB ;
CLARK, JI ;
SPENCE, AM ;
STEELE, JE ;
KROHN, KA ;
LIVESEY, JC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08) :1483-1486
[43]  
MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494
[44]  
NISHIGORI H, 1984, INVEST OPHTH VIS SCI, V25, P1051
[45]   VISUAL AND AUDITORY NEUROTOXICITY IN PATIENTS RECEIVING SUBCUTANEOUS DEFEROXAMINE INFUSIONS [J].
OLIVIERI, NF ;
BUNCIC, JR ;
CHEW, E ;
GALLANT, T ;
HARRISON, RV ;
KEENAN, N ;
LOGAN, W ;
MITCHELL, D ;
RICCI, G ;
SKARF, B ;
TAYLOR, M ;
FREEDMAN, MH .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (14) :869-873
[46]  
OSGOOD TB, 1986, INVEST OPHTH VIS SCI, V27, P1780
[47]  
OSTADALOVA I, 1978, EXPERIENTIA, V34, P222
[48]   SUPPRESSION OF PHASE-SEPARATION IN BOVINE-GAMMA-IV CRYSTALLIN SOLUTIONS - EFFECT OF MODIFICATION BY CHARGED VERSUS UNCHARGED POLAR GROUPS [J].
PANDE, J ;
OGUN, O ;
NATH, C ;
BENEDEK, G .
EXPERIMENTAL EYE RESEARCH, 1993, 57 (03) :257-264
[49]   SUPPRESSION OF PHASE-SEPARATION IN SOLUTIONS OF BOVINE GAMMA-IV-CRYSTALLIN BY POLAR MODIFICATION OF THE SULFUR-CONTAINING AMINO-ACIDS [J].
PANDE, J ;
BERLAND, C ;
BROIDE, M ;
OGUN, O ;
MELHUISH, J ;
BENEDEK, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :4916-4920
[50]  
PANDE J, 1994, INVEST OPHTH VIS SCI, V35, P1810